This trial will study whether a daily inhaled drug can improve aPAP, and will last for 96 weeks total.
- Autoimmune Pulmonary Alveolar Proteinosis
1 Primary · 13 Secondary · Reporting Duration: From screening (6-week) until Follow-up visit (Week 100)
Side Effects for
2 Treatment Groups
1 of 2
1 of 2
160 Total Participants · 2 Treatment Groups
Primary Treatment: Molgramostim · Has Placebo Group · Phase 3
Who is running the clinical trial?
Age 18+ · All Participants · 14 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
For what reasons is Molgramostim typically given to patients?
"While Molgramostim is commonly used to severe infections, it can also be helpful in treating lymphoma, hodgkins, bone marrow transplantation, leukemia, myelocytic, and acute conditions." - Anonymous Online Contributor
Could you please share other examples of research using Molgramostim?
"Currently, there are 46 clinical trials underway for Molgramostim with 6 in Phase 3. Most of these research studies are situated in Seattle, Washington; although, there are a total of 1896 locations running Molgramostim clinical trials." - Anonymous Online Contributor
Is this test being conducted in numerous locations across Canada?
"There are 24 sites conducting this trial, including University Of Arkansas in Little Rock, University Institute of Cardiology and Respirology of Quebec in Québec, Washington U. in St. Louis in Saint Louis." - Anonymous Online Contributor
How many participants are being allowed into this trial?
"In order to properly conduct this trial, we need 160 volunteers that fit the given criteria. Luckily, patients can choose to participate from University Of Arkansas in Little Rock, Arkansas or University Institute of Cardiology and Respirology of Quebec in Québec, Missouri." - Anonymous Online Contributor
Has Molgramostim been given the okay by the FDA?
"Molgramostim falls into the category of a Phase 3 trial, which means that there is efficacy data as well as multiple rounds of safety data. Therefore, it received a score of 3 from our team at Power." - Anonymous Online Contributor
Are patients being enrolled in this experiment at the moment?
"That is correct. The clinical trial, which began recruiting on May 10th, 2021, is still looking for patients. Last updated on September 22nd, the study needs 160 participants from 24 different medical sites." - Anonymous Online Contributor